CS logo
small CS logo
Department of Urology

Turku, Finland
Hospital in Turku
Kiinamyllynkatu 4-8, 20521 Turku
900 Beds

About Department of Urology


Turku University Hospital is a hospital in Turku, Finland.
There are 900 beds in Department of Urology.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Department of Urology


During the past decade, Department of Urology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Urology" #1 collaborator was "University of Turku" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Department of Urology


According to Clinical.Site data, the most researched conditions in "Department of Urology" are "Benign Prostatic Hyperplasia" (1 trials), "Bladder Cancer" (1 trials), "Carcinoma, Transitional Cell" (1 trials), "High Risk Prostate Cancer" (1 trials) and "Localised Prostate Cancer" (1 trials). Many other conditions were trialed in "Department of Urology" in a lesser frequency.

Clinical Trials Intervention Types at Department of Urology


Most popular intervention types in "Department of Urology" are "Drug" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "99mTC-HMDP planar bone scintigraphy (BS)" (1 trials), "99mTc-HMDP single photon emission computer tomography/computer tomography" (1 trials), "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Department of Urology


The vast majority of trials in "Department of Urology" are 2 trials for "All" genders and 2 trials for "Male" genders.

Clinical Trials Status at Department of Urology


Currently, there are NaN active trials in "Department of Urology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Department of Urology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Department of Urology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".